|
07 Sep 2025 |
Max Healthcare
|
Consensus Share Price Target
|
1170.00 |
1251.70 |
- |
6.98 |
buy
|
|
|
|
|
13 Aug 2022
|
Max Healthcare
|
Prabhudas Lilladhar
|
1170.00
|
427.00
|
396.85
(194.82%)
|
Target met |
Buy
|
|
|
|
|
11 Aug 2022
|
Max Healthcare
|
Edelweiss
|
1170.00
|
470.00
|
371.95
(214.56%)
|
Target met |
Buy
|
|
|
Continues to report robust performance
|
|
20 Jun 2022
|
Max Healthcare
|
Edelweiss
|
1170.00
|
470.00
|
362.40
(222.85%)
|
Target met |
Buy
|
|
|
Healthy ARPOB with improvement in occupancy
|
|
30 May 2022
|
Max Healthcare
|
Prabhudas Lilladhar
|
1170.00
|
427.00
|
380.35
(207.61%)
|
Target met |
Buy
|
|
|
|
|
27 May 2022
|
Max Healthcare
|
Edelweiss
|
1170.00
|
470.00
|
374.65
(212.29%)
|
Target met |
Buy
|
|
|
Mixed performance amid margin improvement
|
|
15 Feb 2022
|
Max Healthcare
|
Edelweiss
|
1170.00
|
470.00
|
371.60
(214.85%)
|
Target met |
Buy
|
|
|
In-line performance with robust pickup in non-covid business
|
|
15 Nov 2021
|
Max Healthcare
|
Edelweiss
|
1170.00
|
456.00
|
363.60
(221.78%)
|
Target met |
Buy
|
|
|
Strong performance with healthy pickup in non-covid business
|
|
14 Sep 2021
|
Max Healthcare
|
Joindre Capital Services
|
1170.00
|
|
373.25
(213.46%)
|
|
Buy
|
|
|
|
|
11 Aug 2021
|
Max Healthcare
|
Edelweiss
|
1170.00
|
350.00
|
329.55
(255.03%)
|
Target met |
Buy
|
|
|
Robust performance; Healthy growth to continue
|
|
20 Jul 2021
|
Max Healthcare
|
Edelweiss
|
1170.00
|
331.00
|
259.45
(350.95%)
|
Target met |
Buy
|
|
|
ARPOB improving on bounce-back in non-Covid biz
|